Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
| Actual shortage: | 30 (23%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-PAROXETINE | 10MG | TABLET | Resolved | 2018-01-09 | 2018-04-12 | 35476 |
| MINT-PAROXETINE | 20MG | TABLET | Resolved | 2018-01-09 | 2018-03-03 | 35480 |
| MINT-PERINDOPRIL | 8MG | TABLET | Resolved | 2019-10-09 | 2019-10-22 | 95941 |
| MINT-PRAVASTATIN | 10MG | TABLET TABLET | Resolved | 2024-01-26 | 2024-03-26 | 217375 |
| MINT-PRAVASTATIN | 20MG | TABLET TABLET | Actual shortage | 2024-01-26 | 2024-03-25 | 217378 |
| MINT-PRAVASTATIN | 40MG | TABLET TABLET | Resolved | 2024-01-26 | 2024-03-26 | 217381 |
| MINT-PREGABALIN | 25MG | CAPSULE | Resolved | 2018-01-09 | 2018-02-03 | 35498 |
| MINT-QUETIAPINE | 25MG | TABLET | Resolved | 2018-04-16 | 2018-05-09 | 46030 |
| MINT-ROSUVASTATIN | 5MG | TABLET | Actual shortage | 2019-08-22 | 2019-08-23 | 92272 |
| MINT-ROSUVASTATIN | 10MG | TABLET | Resolved | 2019-01-03 | 2019-02-01 | 71081 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Actual shortage | 2019-08-22 | 2019-08-23 | 92275 |
| MINT-SERTRALINE | 25MG | CAPSULE | Resolved | 2018-01-09 | 2018-03-09 | 35483 |
| MINT-SIMVASTATIN | 5MG | TABLET | Resolved | 2018-01-09 | 2018-02-15 | 35486 |
| MINT-SOLIFENACIN | 5MG | TABLET | Resolved | 2018-01-09 | 2018-03-21 | 35492 |
| MINT-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2021-01-11 | 2021-04-05 | 131333 |
| MINT-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-11-07 | 2018-01-04 | 28570 |
| MINT-AMLODIPINE | 10MG | TABLET | Resolved | 2018-04-12 | 2018-05-29 | 45528 |
| MINT-ATORVASTATIN | 10MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217690 |
| MINT-ATORVASTATIN | 20MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217693 |
| MINT-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217696 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |
| MINT-METFORMIN | 500MG | TABLET | Discontinued | 2019-07-04 | 2019-07-05 | 88513 |
| MINT-RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13556 |
| MINT-RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13559 |
| MINT-RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13562 |
| MINT-RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13565 |
| MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
| MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
| MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |